CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Medical Officer sold 7,771 shares at $0.79 ($6,139)
- 4 Exercise or conversion Director acquired 5,701 shares (option exercise)
- 4 Planned sale President and CEO sold 46,999 shares at $0.82 ($38,539)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.86 ($17,200)
- 4 Open-market sale General Counsel and Secretary sold 12,172 shares at $1.07 ($13,024)
- 4 Open-market sale Chief Medical Officer sold 9,473 shares at $1.07 ($10,136)
- 4 Grant or award Chief Research Officer acquired 12,157 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 11,605 shares (grant or award)
- 4 Exercise or conversion VP & Corporate Controller acquired 12,722 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 14 · 269 filings